HEADER TRANSFERASE 14-NOV-13 4CFD TITLE INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL CHALLENGE COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 50-212; COMPND 5 EC: 2.7.7.7; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: TYPE1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET KEYWDS TRANSFERASE, STRUCTURE BASED DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR T.S.PEAT REVDAT 4 20-DEC-23 4CFD 1 JRNL REMARK REVDAT 3 25-JUN-14 4CFD 1 JRNL REVDAT 2 26-FEB-14 4CFD 1 JRNL REVDAT 1 27-NOV-13 4CFD 0 JRNL AUTH T.S.PEAT,O.DOLEZAL,J.NEWMAN,D.MOBLEY,J.J.DEADMAN JRNL TITL INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL JRNL TITL 2 CHALLENGE. JRNL REF J.COMPUT.AIDED MOL.DES. V. 28 347 2014 JRNL REFN ISSN 0920-654X JRNL PMID 24532034 JRNL DOI 10.1007/S10822-014-9721-7 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 18852 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1001 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1493 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE SET COUNT : 75 REMARK 3 BIN FREE R VALUE : 0.3010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2318 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 112 REMARK 3 SOLVENT ATOMS : 93 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : -0.39000 REMARK 3 B12 (A**2) : 0.12000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.263 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.197 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.125 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.908 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.901 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2583 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2495 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3532 ; 1.310 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5754 ; 0.787 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 326 ; 5.619 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;29.237 ;25.327 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 447 ;14.875 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;12.247 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 394 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2949 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 579 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1232 ; 2.256 ; 4.041 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1227 ; 2.252 ; 4.035 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1539 ; 3.788 ; 6.763 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1351 ; 2.463 ; 4.520 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4CFD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1290058975. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95367 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20849 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 62.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3ZSQ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE PROTEIN WAS CONCENTRATED TO 5.5 REMARK 280 MG/ML IN 40 MM TRIS PH 8.0, 250 MM NACL, 30 MM MGCL2, 5 MM DTT REMARK 280 AND SET UP IN A 1:1 RATIO WITH 1.6 TO 2.0 M AMMONIUM SULFATE, REMARK 280 100 MM SODIUM ACETATE BUFFER PH 5.0 TO 5.5., PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 22.19167 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.38333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -121.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 30 REMARK 465 GLY A 31 REMARK 465 SER A 32 REMARK 465 SER A 33 REMARK 465 HIS A 34 REMARK 465 HIS A 35 REMARK 465 HIS A 36 REMARK 465 HIS A 37 REMARK 465 HIS A 38 REMARK 465 HIS A 39 REMARK 465 SER A 40 REMARK 465 SER A 41 REMARK 465 GLY A 42 REMARK 465 LEU A 43 REMARK 465 VAL A 44 REMARK 465 PRO A 45 REMARK 465 ARG A 46 REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 HIS A 49 REMARK 465 MET A 50 REMARK 465 HIS A 51 REMARK 465 GLY A 52 REMARK 465 GLN A 53 REMARK 465 VAL A 54 REMARK 465 ASP A 55 REMARK 465 SER A 56 REMARK 465 GLY A 189 REMARK 465 GLY A 190 REMARK 465 ILE A 191 REMARK 465 GLY A 192 REMARK 465 THR A 210 REMARK 465 LYS A 211 REMARK 465 GLU A 212 REMARK 465 MET B 30 REMARK 465 GLY B 31 REMARK 465 SER B 32 REMARK 465 SER B 33 REMARK 465 HIS B 34 REMARK 465 HIS B 35 REMARK 465 HIS B 36 REMARK 465 HIS B 37 REMARK 465 HIS B 38 REMARK 465 HIS B 39 REMARK 465 SER B 40 REMARK 465 SER B 41 REMARK 465 GLY B 42 REMARK 465 LEU B 43 REMARK 465 VAL B 44 REMARK 465 PRO B 45 REMARK 465 ARG B 46 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 HIS B 49 REMARK 465 MET B 50 REMARK 465 HIS B 51 REMARK 465 GLY B 52 REMARK 465 GLN B 53 REMARK 465 VAL B 54 REMARK 465 ASP B 55 REMARK 465 SER B 56 REMARK 465 GLY B 189 REMARK 465 GLY B 190 REMARK 465 ILE B 191 REMARK 465 GLY B 192 REMARK 465 THR B 210 REMARK 465 LYS B 211 REMARK 465 GLU B 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ACT A 1214 O HOH A 2009 1.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 147 -97.84 65.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1212 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 1213 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 1214 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1216 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S8Y B 1215 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S8Y A 1217 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CE9 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEA RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEB RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEC RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CED RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEE RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEF RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEO RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEQ RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CER RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CES RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CEZ RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CF0 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CF1 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CF2 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CF8 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CF9 RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CFA RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CFB RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE REMARK 900 RELATED ID: 4CFC RELATED DB: PDB REMARK 900 INTERROGATING HIV INTEGRASE FOR COMPOUNDS THAT BIND- A SAMPL REMARK 900 CHALLENGE DBREF 4CFD A 50 212 UNP Q76353 Q76353_9HIV1 50 212 DBREF 4CFD B 50 212 UNP Q76353 Q76353_9HIV1 50 212 SEQADV 4CFD MET A 30 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY A 31 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 32 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 33 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 34 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 35 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 36 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 37 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 38 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 39 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 40 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 41 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY A 42 UNP Q76353 EXPRESSION TAG SEQADV 4CFD LEU A 43 UNP Q76353 EXPRESSION TAG SEQADV 4CFD VAL A 44 UNP Q76353 EXPRESSION TAG SEQADV 4CFD PRO A 45 UNP Q76353 EXPRESSION TAG SEQADV 4CFD ARG A 46 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY A 47 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 48 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS A 49 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER A 56 UNP Q76353 CYS 56 ENGINEERED MUTATION SEQADV 4CFD ASP A 139 UNP Q76353 PHE 139 ENGINEERED MUTATION SEQADV 4CFD HIS A 185 UNP Q76353 PHE 185 ENGINEERED MUTATION SEQADV 4CFD MET B 30 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY B 31 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 32 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 33 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 34 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 35 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 36 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 37 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 38 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 39 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 40 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 41 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY B 42 UNP Q76353 EXPRESSION TAG SEQADV 4CFD LEU B 43 UNP Q76353 EXPRESSION TAG SEQADV 4CFD VAL B 44 UNP Q76353 EXPRESSION TAG SEQADV 4CFD PRO B 45 UNP Q76353 EXPRESSION TAG SEQADV 4CFD ARG B 46 UNP Q76353 EXPRESSION TAG SEQADV 4CFD GLY B 47 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 48 UNP Q76353 EXPRESSION TAG SEQADV 4CFD HIS B 49 UNP Q76353 EXPRESSION TAG SEQADV 4CFD SER B 56 UNP Q76353 CYS 56 ENGINEERED MUTATION SEQADV 4CFD ASP B 139 UNP Q76353 PHE 139 ENGINEERED MUTATION SEQADV 4CFD HIS B 185 UNP Q76353 PHE 185 ENGINEERED MUTATION SEQRES 1 A 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 183 LEU VAL PRO ARG GLY SER HIS MET HIS GLY GLN VAL ASP SEQRES 3 A 183 SER SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 4 A 183 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 5 A 183 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 6 A 183 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 7 A 183 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 8 A 183 PHE THR SER THR THR VAL LYS ALA ALA CYS TRP TRP ALA SEQRES 9 A 183 GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN PRO GLN SEQRES 10 A 183 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 11 A 183 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 12 A 183 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN HIS SEQRES 13 A 183 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 14 A 183 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN THR LYS SEQRES 15 A 183 GLU SEQRES 1 B 183 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 183 LEU VAL PRO ARG GLY SER HIS MET HIS GLY GLN VAL ASP SEQRES 3 B 183 SER SER PRO GLY ILE TRP GLN LEU ASP CYS THR HIS LEU SEQRES 4 B 183 GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL ALA SER SEQRES 5 B 183 GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU THR GLY SEQRES 6 B 183 GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA GLY ARG SEQRES 7 B 183 TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SER ASN SEQRES 8 B 183 PHE THR SER THR THR VAL LYS ALA ALA CYS TRP TRP ALA SEQRES 9 B 183 GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN PRO GLN SEQRES 10 B 183 SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU LEU LYS SEQRES 11 B 183 LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU HIS LEU SEQRES 12 B 183 LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS ASN HIS SEQRES 13 B 183 LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA GLY GLU SEQRES 14 B 183 ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN THR LYS SEQRES 15 B 183 GLU HET SO4 A1210 5 HET SO4 A1211 5 HET SO4 A1212 5 HET ACT A1213 4 HET ACT A1214 4 HET ACT A1215 4 HET CL A1216 1 HET S8Y A1217 32 HET SO4 B1210 5 HET SO4 B1211 5 HET SO4 B1212 5 HET ACT B1213 4 HET CL B1214 1 HET S8Y B1215 32 HETNAM SO4 SULFATE ION HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM S8Y 5-[[[(1R)-2-(TERT-BUTYLAMINO)-2-OXIDANYLIDENE-1-PHENYL- HETNAM 2 S8Y ETHYL]CARBAMOYL-METHYL-AMINO]METHYL]-1,3-BENZODIOXOLE- HETNAM 3 S8Y 4-CARBOXYLIC ACID FORMUL 3 SO4 6(O4 S 2-) FORMUL 6 ACT 4(C2 H3 O2 1-) FORMUL 9 CL 2(CL 1-) FORMUL 10 S8Y 2(C23 H27 N3 O6) FORMUL 17 HOH *93(H2 O) HELIX 1 1 THR A 93 TRP A 108 1 16 HELIX 2 2 ASN A 117 SER A 123 1 7 HELIX 3 3 SER A 123 GLY A 134 1 12 HELIX 4 4 SER A 147 ARG A 166 1 20 HELIX 5 5 ASP A 167 ALA A 169 5 3 HELIX 6 6 HIS A 171 LYS A 186 1 16 HELIX 7 7 SER A 195 GLN A 209 1 15 HELIX 8 8 THR B 93 TRP B 108 1 16 HELIX 9 9 ASN B 117 SER B 123 1 7 HELIX 10 10 SER B 123 GLY B 134 1 12 HELIX 11 11 ASN B 144 ARG B 166 1 23 HELIX 12 12 ASP B 167 ALA B 169 5 3 HELIX 13 13 HIS B 171 LYS B 186 1 16 HELIX 14 14 SER B 195 GLN B 209 1 15 SHEET 1 AA 5 ILE A 84 ILE A 89 0 SHEET 2 AA 5 LYS A 71 HIS A 78 -1 O VAL A 72 N ILE A 89 SHEET 3 AA 5 ILE A 60 LEU A 68 -1 O GLN A 62 N VAL A 77 SHEET 4 AA 5 THR A 112 THR A 115 1 O THR A 112 N TRP A 61 SHEET 5 AA 5 LYS A 136 ASP A 139 1 O LYS A 136 N VAL A 113 SHEET 1 BA 5 ILE B 84 ILE B 89 0 SHEET 2 BA 5 LYS B 71 HIS B 78 -1 O VAL B 72 N ILE B 89 SHEET 3 BA 5 ILE B 60 LEU B 68 -1 O GLN B 62 N VAL B 77 SHEET 4 BA 5 THR B 112 THR B 115 1 O THR B 112 N TRP B 61 SHEET 5 BA 5 LYS B 136 ASP B 139 1 O LYS B 136 N VAL B 113 CISPEP 1 GLN A 146 SER A 147 0 -24.54 SITE 1 AC1 5 THR B 66 HIS B 67 LYS B 111 LYS B 136 SITE 2 AC1 5 LYS B 159 SITE 1 AC2 5 THR A 66 HIS A 67 LYS A 111 LYS A 159 SITE 2 AC2 5 HOH A2035 SITE 1 AC3 4 LYS B 71 HIS B 171 LEU B 172 HOH B2031 SITE 1 AC4 4 LYS A 71 HIS A 171 LEU A 172 HOH A2040 SITE 1 AC5 7 GLY A 94 SER A 123 THR A 124 THR A 125 SITE 2 AC5 7 HOH A2013 HOH A2014 HOH A2028 SITE 1 AC6 8 GLY B 94 GLN B 95 SER B 123 THR B 124 SITE 2 AC6 8 THR B 125 HOH B2012 HOH B2013 HOH B2021 SITE 1 AC7 5 TYR A 99 LYS A 103 ACT A1214 HOH A2017 SITE 2 AC7 5 HOH B2008 SITE 1 AC8 5 ACT A1213 HOH A2008 HOH A2009 TYR B 99 SITE 2 AC8 5 LYS B 103 SITE 1 AC9 3 GLU A 85 PHE A 100 LYS A 103 SITE 1 BC1 3 ARG A 107 GLU B 85 PHE B 100 SITE 1 BC2 1 HIS B 185 SITE 1 BC3 1 HIS A 185 SITE 1 BC4 8 GLN A 95 ALA A 128 GLN B 168 ALA B 169 SITE 2 BC4 8 GLU B 170 HIS B 171 THR B 174 HOH B2033 SITE 1 BC5 10 ASP A 167 GLN A 168 ALA A 169 GLU A 170 SITE 2 BC5 10 HIS A 171 THR A 174 HOH A2041 HOH A2053 SITE 3 BC5 10 GLN B 95 ALA B 128 CRYST1 71.691 71.691 66.575 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013949 0.008053 0.000000 0.00000 SCALE2 0.000000 0.016107 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015021 0.00000